ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012

Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.

November 9, 2001

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014